表紙
市場調査レポート

インドの不妊症治療の市場機会 (2020年)

India Infertility Treatments Market Opportunities, 2020

発行 Pharmaion 商品コード 346842
出版日 ページ情報 英文 91 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。
Back to Top
インドの不妊症治療の市場機会 (2020年) India Infertility Treatments Market Opportunities, 2020
出版日: 2015年12月11日 ページ情報: 英文 91 Pages
概要

インドでは不妊症は非常にデリケートな問題で、個人も家族も深刻な心理的・感情的・社会的ストレスに直面することになります。2014年には、インド国内の夫婦の10〜15%が「自分たちは不妊症に罹っている」と考えています。また、毎年平均で約4万件の不妊症の治療手術が施されています。また、インド国内の不妊症治療市場は、2015〜2020年に13%以上の年平均成長率 (CAGR) で成長する、と推計されています。市場の主な成長要因として、女性の妊娠年齢が上昇したことや、ライフスタイルの変化、避妊薬の利用増加、女性の飲酒・喫煙の拡大などが挙げられます。他方、政府の規制や監督体制が整備されてないため、企業の大半が小規模・無名な企業となっています。不妊症の治療方法には様々な種類がありますが、現在は生殖補助治療 (ART:体外受精など) が中心となっています。

当レポートでは、インド国内の不妊症治療市場について分析し、全体的な市場規模・シェアの動向見通し (通算11年間分) や、治療法の種類別および地域別・企業の種類別の詳細動向、政策・規制環境、主要企業のプロファイル、市場構造の変化と今後の市場機会、関係者への提言といった内容を取りまとめてお届けいたします。

第1章 製品概要

第2章 アナリストの見解

第3章 分析手法

第4章 世界の不妊治療市場の概要

第5章 インドの不妊症治療市場の展望

  • 市場規模とその予測 (金額ベース)
  • 市場シェアとその予測
    • 種類別 (ART、排卵誘発剤、手術)
    • 地域別 (南部・西部・北部・東部)
    • 企業の種類別 (ブランド企業、非ブランド企業)

第6章 排卵誘発剤市場の展望

  • 市場規模とその予測 (金額ベース)
  • 市場シェアとその予測
    • 種類別 (ホルモン剤、合成剤)
    • 男女別

第7章 不妊症治療手術市場の展望

  • 市場規模とその予測 (金額ベース)
  • 市場シェアとその予測:男女別

第8章 インドのART (生殖補助治療) 市場の展望

  • 市場規模とその予測 (金額ベース)
  • 市場シェアとその予測
    • 種類別 (体外受精 (IFV)、代理母、人工授精 (IUI) など)

第9章 市場のダイナミクス

  • 市場促進要因
  • 市場の課題

第10章 市場の傾向と発展

  • メディカルツーリズムと「不妊治療観光」
  • 連続性不妊症の増加
  • 小都市での不妊治療クリニックの増加
  • 卵巣予備能の検査のためのAMH (抗ミュラー管ホルモン)
  • 遺伝子異常の発見のためのアレイCGH (比較ゲノムハイブリダイゼーション)

第11章 政策・規制環境

第12章 インド経済のプロファイル

第13章 競争環境

  • 競争マトリックス
  • 企業プロファイル
    • Nova IVI Fertility
    • Bourn Hall International India Pvt. Ltd.
    • Morpheus Life Sciences Pvt. Ltd.
    • Dr. Rama's Institute for Fertility
    • Moolchand Fertility & IVF
    • Sun Pharmaceutical Industries Ltd.
    • Cadila Healthcare Ltd.
    • Cipla Ltd.
    • Abbott India Limited
    • GlaxoSmithKline Pharmaceuticals Limited

戦略提言

図表一覧

目次

In India, infertility is a highly sensitive matter and is linked with serious psychological, emotional and social distress to an individual as well as to his/her family. About 10-15% of Indian married couples were believed to be suffering from infertility in 2014. Infertility occurs in both males and females; however, female infertility dominates the infertility treatments market in India. On an average, approximately 40,000 infertility treatment cycles are being performed across the country every year. For curing infertility, three treatments, namely, Fertility Drugs, Surgery, and Assisted Reproductive Treatments (ARTs), are being adopted across the country. Among these treatments, ART is the most widely adopted treatment option as it involves handing of both male sperm and female egg, which is not possible in other two types of treatments.

According to Pharmaion report, “India Infertility Treatments Market Opportunities, 2020”, infertility treatments market in India is anticipated to grow at a CAGR of over 13% during 2015 - 2020. Growth in the market is anticipated on account of visible increase in the reproductive age of women, changing lifestyle, increasing use of contraceptives and rising consumption of alcohol and cigarettes. The largest market share in India infertility treatments market was captured by the country's Southern region, due to increasing medical tourism and easy availability of skilled medical professionals in the region. Owing to lesser government regulations and absence of a centralized regulatory body, India infertility treatments market is being dominated by small and unbranded players. Some of the major players operating in India infertility treatments market include Nova IVI Fertility, Bourn Hall International India Pvt. Ltd., Morpheus Life Sciences Pvt. Ltd., and Dr. Rama's Institute for Fertility, among others.

“India Infertility Treatments Market Opportunities, 2020” discusses the following aspects related to infertility treatments market in India:

  • India Infertility Treatments Market Size, Share & Forecast
  • Segmental Analysis - By Type, By Region & By Company Type
  • Policy & Regulatory Landscape
  • Changing Market Trends & Emerging Opportunities
  • Competitive Landscape & Strategic Recommendations

Why You Should Buy This Report?

  • To identify the on-going trends and anticipated growth over the next five years
  • To gain competitive knowledge of leading market players
  • To avail 10% customization in the report without any extra charges and get the research data or trends added in the report as per the buyer's specific needs.

Table of Contents

1. Product Overview

2. Analyst View

3. Research Methodology

4. Global Fertility Treatments Market Overview

5. India Fertility Treatments Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (ART, Fertility Drugs & Surgery)
    • 5.2.2. By Region (South, West, North & Others)
    • 5.2.3. By Company Type (Branded & Unbranded)

6. India Fertility Drugs Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Hormonal Drugs & Synthetic Drugs)
    • 6.2.2. By Gender (Female & Male)
      • 6.2.2.1. Hormonal Drugs
      • 6.2.2.2. Synthetic Drugs

7. India Infertility Treatment Surgery Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Gender (Female & Male)

8. India ART Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type (IVF, Surrogacy, IUI & Others)

9. Market Dynamics

  • 9.1. Drivers
  • 9.2. Challenges

10. Market Trends & Developments

  • 10.1. Medical Tourism & Fertility Tourism
  • 10.2. Rising Secondary Infertility
  • 10.3. Increasing Penetration of Infertility Clinics in Small Towns
  • 10.4. AMH for Testing Ovarian Reserve
  • 10.5. Array CGH for Detecting Genetic Abnormalities

11. Policy & Regulatory Landscape

12. India Economic Profile

13. Competition Landscape

  • 13.1. Competition Matrix
  • 13.2. Company Profiles
    • 13.2.1. Nova IVI Fertility
    • 13.2.2. Bourn Hall International India Pvt. Ltd.
    • 13.2.3. Morpheus Life Sciences Pvt. Ltd.
    • 13.2.4. Dr. Rama's Institute for Fertility
    • 13.2.5. Moolchand Fertility & IVF
    • 13.2.6. Sun Pharmaceutical Industries Ltd.
    • 13.2.7. Cadila Healthcare Ltd.
    • 13.2.8. Cipla Ltd.
    • 13.2.9. Abbott India Limited
    • 13.2.10. GlaxoSmithKline Pharmaceuticals Limited

Strategic Recommendations

List of Figures

  • Figure 1: India Infertility Treatments Market Size, By Value, 2010-2020F (USD Billion)
  • Figure 2: Share of Infertility Factor among Indian Couples, 2014
  • Figure 3: India Infertility Treatments Market Share, By Type, By Value, 2010-2020F
  • Figure 4: India Infertility Treatments Market Share, By Region, By Value, 2010-2020F
  • Figure 5: India Infertility Treatments Market Share, By Company Type, By Value, 2010-2020F
  • Figure 6: India Fertility Drugs Market Size, By Value, 2010-2020F (USD Billion)
  • Figure 7: India Fertility Drugs Market Share, By Type, By Value, 2010-2020F
  • Figure 8: India Fertility Drugs Market Share, By Gender, By Value, 2014 & 2020F
  • Figure 9: India Fertility Hormonal Drugs Market Share, By Gender, By Value, 2010-2020F
  • Figure 10: India Fertility Synthetic Drugs Market Share, By Gender, By Value, 2010-2020F
  • Figure 11: India Infertility Treatment Surgery Market Size, By Value, 2010-2020F (USD Billion)
  • Figure 12: India Infertility Treatment Surgery Market Share, By Gender, By Value, 2010-2020F
  • Figure 13: India ART Market Size, By Value, 2010-2020F (USD Billion)
  • Figure 14: India ART Market Share, By Type, By Value, 2010-2020F
  • Figure 15: India Medical Tourism Market Size, By Value, 2010-2020F (USD Billion)
  • Figure 16: India Medical Tourists Share, By State, 2013

List of Tables

  • Table 1: Risk Factors Leading to Infertility
  • Table 2: Infertility Treatment Drugs - Pros & Cons
  • Table 3: Surgery for Infertility Treatment - Pros & Cons
  • Table 4: Types of ART Treatments
  • Table 5: ART - Pros & Cons
  • Table 6: South India Female Infertility Prevalence Rate, 2014 (%)
  • Table 7: West India Female Infertility Prevalence Rate, 2014 (%)
  • Table 8: North India Female Infertility Prevalence Rate, 2014 (%)
  • Table 9: North India Female Infertility Prevalence Rate, 2014 (%)
  • Table 10: Surgical Sperm Retrieval Procedures Required in Various ART Treatments
  • Table 11: Secondary Infertility Cases in Major Indian Cities, 2014
  • Table 12: Number of Infertility Clinics, By State, 2014
Back to Top